IMR Stock Overview
A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Imricor Medical Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.59 |
| 52 Week High | AU$0.85 |
| 52 Week Low | AU$0.41 |
| Beta | 0.26 |
| 11 Month Change | 16.83% |
| 3 Month Change | 18.00% |
| 1 Year Change | 35.63% |
| 33 Year Change | -64.35% |
| 5 Year Change | n/a |
| Change since IPO | -59.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| IMR | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -6.0% | 0.3% | -2.2% |
| 1Y | 35.6% | 24.5% | 5.4% |
Return vs Industry: IMR exceeded the Australian Medical Equipment industry which returned 24.5% over the past year.
Return vs Market: IMR exceeded the Australian Market which returned 5.4% over the past year.
Price Volatility
| IMR volatility | |
|---|---|
| IMR Average Weekly Movement | 8.4% |
| Medical Equipment Industry Average Movement | 9.8% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in AU Market | 16.4% |
| 10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: IMR's share price has been volatile over the past 3 months.
Volatility Over Time: IMR's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Steve Wedan | www.imricor.com |
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company’s principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning.
Imricor Medical Systems, Inc. Fundamentals Summary
| IMR fundamental statistics | |
|---|---|
| Market cap | AU$117.66m |
| Earnings (TTM) | -AU$34.48m |
| Revenue (TTM) | AU$938.13k |
125.4x
P/S Ratio-3.4x
P/E RatioIs IMR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IMR income statement (TTM) | |
|---|---|
| Revenue | US$615.57k |
| Cost of Revenue | US$1.73m |
| Gross Profit | -US$1.12m |
| Other Expenses | US$21.51m |
| Earnings | -US$22.63m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | -181.27% |
| Net Profit Margin | -3,675.61% |
| Debt/Equity Ratio | -101.1% |
How did IMR perform over the long term?
See historical performance and comparison